SARS-CoV-2 viral dynamics in infections with Alpha and Beta variants of concern in the French community

      We read with interest the article by Tang et al. on the multiple introductions of variant B.1.351 into the UK.
      • Tang J.W.
      • Toovey O.T.R.
      • Harvey K.N.
      • Hui D.D.S.
      Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK.
      As SARS-CoV-2 variants of concern rapidly spread internationally, it is important to
      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Journal of Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Tang J.W.
        • Toovey O.T.R.
        • Harvey K.N.
        • Hui D.D.S.
        Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK.
        J Infect. 2021; 82 (Apr): e8-10
        • Volz E.
        • Mishra S.
        • Chand M.
        • Barrett J.C.
        • Johnson R.
        • Geidelberg L.
        • et al.
        Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.
        Nature. 2021; 593 (Mar 25): 266-269https://doi.org/10.1038/s41586-021-03470-x
        • Davies N.G.
        • Abbott S.
        • Barnard R.C.
        • Jarvis C.I.
        • Kucharski A.J.
        • Munday J.D.
        • et al.
        Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.
        Science. 2021; 372 ([Internet]Apr 9 [cited 2021 Apr 16]Available from:)
        • Gaymard A.
        • Bosetti P.
        • Feri A.
        • Destras G.
        • Enouf V.
        • Andronico A.
        • et al.
        Early assessment of diffusion and possible expansion of SARS-CoV-2 lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021.
        Eurosurveillance. 2021; 26 (Mar 4)2100133
        • Davies N.G.
        • Jarvis C.I.
        • Edmunds W.J.
        • Jewell N.P.
        • Diaz-Ordaz K.
        • Keogh R.H.
        Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7.
        Nature. 2021; 593 (Mar 15): 270-274https://doi.org/10.1038/s41586-021-03426-1
        • Hay J.A.
        • Kennedy-Shaffer L.
        • Kanjilal S.
        • Lennon N.J.
        • Gabriel S.B.
        • Lipsitch M.
        • et al.
        Estimating epidemiologic dynamics from cross-sectional viral load distributions.
        Science. 2021; 373 ([Internet]Jun 3 [cited 2021 Jun 28]; Available from): eabh0635https://doi.org/10.1126/science.abh0635
        • Vaida F.
        • Liu L.
        Fast implementation for normal mixed effects models with censored response.
        J Comput Graph Stat. 2009; 18 (Jan 1): 797-817
      1. SPF. COVID-19 : point épidémiologique du 18 mars 2021 [Internet]. [cited 2021 Apr 17]. Available from: /maladies-et-traumatismes/maladies-et-infections-respiratoires/infection-a-coronavirus/documents/bulletin-national/covid-19-point-epidemiologique-du-18-mars-2021

      2. Kissler S.M., Fauver J.R., Mack C., Tai C.G., Breban M.I., Watkins A.E., et al. Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2. medRxiv. 2021 Feb 19;2021.02.16.21251535.

        • Marks M.
        • Millat-Martinez P.
        • Ouchi D.
        • Roberts C.H
        • Alemany A.
        • Corbacho-Monné M.
        • et al.
        Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study.
        Lancet Infect Dis. 2021; 21 ([Internet]Feb 2 [cited 2021 Apr 12]; Available from:): 629-636https://doi.org/10.1016/S1473-3099(20)30985-3